Option delistings effective December 23rd include Pieris Pharmaceuticals (PVLA), Nanostring Technologies, Inc. (NSTGQ), NaaS Technology (NAAS), ROUNDHILL DAILY INVERSE MAGNIFICENT SEVEN ETF (MAGQ), Merrimack Pharmaceuticals Inc (MACK), Cue Health Inc (HLTHQ), Galera Therapeutics Inc (GRTX), DermTech Inc (DMTKQ), Cidara Therapeutics (CDTX), Nuburu, Inc. (BURU), Atara Biotherapeutics (ATRA), and RCM Technologies (RCMT).
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PVLA: